Claudio Chuaqui

2.5k citations

26 papers · 1.4k indexed · h-index 17

Molecular Biology top 10%
Computational Theory and Mathematics top 1%
Organic Chemistry top 5%
Oncology top 10%
Pharmacology top 10%

Co-authors: Juswinder Singh Zhan Deng Nancy Su Michelle L. Lamb Qibin Su Neil P. Grimster Brian Aquila Alexander W. Hird
Topics: Computational Drug Discovery Methods (8 papers)Protein Kinase Regulation and GTPase Signaling (5 papers)Microbial Natural Products and Biosynthesis (4 papers)
Cited by: Computational Theory and Mathematics Molecular Biology Organic Chemistry
Journals: Cancer Research Journal of Medicinal Chemistry Nature Chemical Biology
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Claudio Chuaqui

25 papers receiving 1.4k citations

Peers

Countries citing papers authored by Claudio Chuaqui

Since Specialization

Citations

This map shows the geographic impact of Claudio Chuaqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Chuaqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Chuaqui more than expected).

Fields of papers citing papers by Claudio Chuaqui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Chuaqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Chuaqui. The network helps show where Claudio Chuaqui may publish in the future.

Co-authorship network of co-authors of Claudio Chuaqui

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Chuaqui. A scholar is included among the top collaborators of Claudio Chuaqui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Chuaqui. Claudio Chuaqui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 979: Discovery of the JAK1 selective kinase inhibitor AZD4205 2017 ·Cancer Research ·Jason G. Kettle,Qibin Su,Neil P. Grimster,Sameer Kawatkar,Scott Throner,Richard Woessner,Huawei Chen,Geraldine Bebernitz,Kristen Bell,Erica Anderson,Linette Ruston,(unknown),Paul D. Lyne,Melissa M. Vasbinder,Claudio Chuaqui	5
2	Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain 2016 ·Nature Chemical Biology ·(unknown),Matthew A. Belmonte,Brian Aquila,Claudio Chuaqui,Alexander W. Hird,Michelle L. Lamb,Philip B. Rawlins,Nancy Su,Sharon Tentarelli,Neil P. Grimster,Qibin Su	162
3	Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors 2016 ·ACS Medicinal Chemistry Letters ·William McCoull,Edward J. Hennessy,Kevin Blades,Claudio Chuaqui,James J. Dowling,Andrew D. Ferguson,Frederick W. Goldberg,(unknown),Christopher R. Jones,Paul D. Kemmitt,Gillian M. Lamont,Jeffrey Varnes,Richard A. Ward,Bin Yang	20
4	Utilization of Structure-Based Design to Identify Novel, Irreversible Inhibitors of EGFR Harboring the T790M Mutation 2016 ·ACS Medicinal Chemistry Letters ·Edward J. Hennessy,Claudio Chuaqui,Susan Ashton,Nicola Colclough,Darren A.E. Cross,J.E. Debreczeni,Cath Eberlein,Lakshmaiah Gingipalli,Teresa Klinowska,Jonathan P. Orme,Sha Li,Xiaoyun Wu	7
5	Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo 2016 ·ACS Medicinal Chemistry Letters ·James J. Dowling,Marat Alimzhanov,(unknown),Claudio Chuaqui,Christopher R. Denz,Emma Jenkins,Nicholas Larsen,Paul D. Lyne,Timothy Pontz,Qing Ye,Geoffrey A. Holdgate,(unknown),Nichole O’Connell,Andrew D. Ferguson	42
6	Discovery of 6-aryl-azabenzimidaoles that inhibit the TBK1/IKK-ε kinases 2014 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Johannes,Claudio Chuaqui,Scott D. Cowen,(unknown),Lakshmaiah Gingipalli,Audrey Molina,Tao Wang,(unknown),Xiaoyun Wu,Haijun Zhang,Michael Zinda	13
7	Identification and optimisation of 7-azaindole PAK1 inhibitors with improved potency and kinase selectivity 2014 ·MedChemComm ·William McCoull,Edward J. Hennessy,Kevin Blades,Matthew Box,Claudio Chuaqui,James J. Dowling,(unknown),Andrew D. Ferguson,Frederick W. Goldberg,(unknown),Paul D. Kemmitt,Gillian M. Lamont,(unknown),Claire McWhirter,Jeffrey Varnes,Richard A. Ward,Jason D. Williams,Bin Yang	14
8	Discovery of Potent KIFC1 Inhibitors Using a Method of Integrated High-Throughput Synthesis and Screening 2014 ·Journal of Medicinal Chemistry ·Bin Yang,Michelle L. Lamb,Tao Zhang,Edward J. Hennessy,Gurmit Grewal,(unknown),(unknown),M. Block,James J. Dowling,Nancy Su,Jiaquan Wu,Tracy L. Deegan,Keith Mikule,Wenxian Wang,Rüdiger Kaspera,Claudio Chuaqui,Huawei Chen	35
9	Abstract 931: Highly selective JAK1 kinase inhibitors suppress Y705-mediated STAT3 activation in a wide range of tumor types, with reduced hematological toxicity. 2013 ·Cancer Research ·Richard Woessner,Geraldine Bebernitz,Kirsten Bell,Robert Caccese,(unknown),Jason G. Kettle,(unknown),Patricia Schroeder,Qibin Su,Haixia Wang,Minwei Ye,Weijia Zheng,Michael Zinda,Paul D. Lyne,Melissa M. Vasbinder,Dennis Huszar,Claudio Chuaqui	0
10	Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo 2013 ·ACS Medicinal Chemistry Letters ·James J. Dowling,Marat Alimzhanov,(unknown),M. Block,Claudio Chuaqui,(unknown),Christopher R. Denz,(unknown),(unknown),Nicholas Larsen,Bo Peng,Timothy Pontz,(unknown),Jamal Saeh,Kumar Thakur,Qing Ye,Tao Zhang,Paul D. Lyne	41
11	Discovery and Mechanistic Study of a Small Molecule Inhibitor for Motor Protein KIFC1 2013 ·ACS Chemical Biology ·Jiaquan Wu,Keith Mikule,Wenxian Wang,Nancy Su,Philip Petteruti,Farzin Gharahdaghi,Erin Code,Xiahui Zhu,Kelly Jacques,Zhongwu Lai,Bin Yang,Michelle L. Lamb,Claudio Chuaqui,Nicholas Keen,Huawei Chen	85
12	Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinases 2012 ·Bioorganic & Medicinal Chemistry Letters ·Tao Wang,(unknown),Scott D. Cowen,Audrey M. Davies,(unknown),Lakshmaiah Gingipalli,Jeffrey W. Johannes,Nicholas Larsen,Qibin Su,Julie A. Tucker,(unknown),Jiaquan Wu,Haijun Zhang,Michael Zinda,Claudio Chuaqui	38
13	Pyrazolone based TGFβR1 kinase inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Kevin M. Guckian,(unknown),Edward Yin-Shiang Lin,Michael Y. Choi,Lihong Sun,P. Ann Boriack‐Sjodin,Claudio Chuaqui,Benjamin C. Lane,Kam Lau Cheung,Leona Ling,Wen‐Cherng Lee	23
14	2-Aminoimidazoles inhibitors of TGF-β receptor 1 2008 ·Bioorganic & Medicinal Chemistry Letters ·D. Bonafoux,Claudio Chuaqui,P. Ann Boriack‐Sjodin,Chris Fitch,(unknown),Serene Josiah,Cheryl Black,(unknown),Leona Ling,Wen‐Cherng Lee	26
15	A Kinase‐focused Compound Collection: Compilation and Screening Strategy 2006 ·Chemical Biology & Drug Design ·Dongyu Sun,Claudio Chuaqui,Zhan Deng,Scott Bowes,Donovan N. Chin,Juswinder Singh,Patrick Cullen,(unknown),Wen‐Cherng Lee,J.Elisabeth Donnelly,Jessica Friedman,Serene Josiah	14
16	Structural Interaction Fingerprints: A New Approach to Organizing, Mining, Analyzing, and Designing Protein–Small Molecule Complexes 2005 ·Chemical Biology & Drug Design ·Juswinder Singh,Zhan Deng,(unknown),Claudio Chuaqui	57
17	Integration of Virtual Screening into the Drug Discovery Process 2004 ·Mini-Reviews in Medicinal Chemistry ·Darin Chin,Claudio Chuaqui,Joginder Singh	12
18	Interaction Profiles of Protein Kinase−Inhibitor Complexes and Their Application to Virtual Screening 2004 ·Journal of Medicinal Chemistry ·Claudio Chuaqui,Zhan Deng,Juswinder Singh	68
19	Successful shape-Based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI) 2003 ·Bioorganic & Medicinal Chemistry Letters ·Juswinder Singh,Claudio Chuaqui,P. Ann Boriack‐Sjodin,Wen‐Cherng Lee,Timothy Pontz,Michael J. Corbley,Hung Kam Cheung,Robert M. Arduini,(unknown),Miki Newman,(unknown),Scott Bowes,Serene Josiah,Leona Ling	133
20	Structural Interaction Fingerprint (SIFt): A Novel Method for Analyzing Three-Dimensional Protein−Ligand Binding Interactions 2003 ·Journal of Medicinal Chemistry ·Zhan Deng,Claudio Chuaqui,Juswinder Singh	434

About Claudio Chuaqui

Claudio Chuaqui is a scholar working on Computational Theory and Mathematics, Genetics and Immunology and Allergy, having authored 26 papers that have together received 1.4k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (8 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Microbial Natural Products and Biosynthesis (4 papers). The work is most often cited by research in Computational Theory and Mathematics (592 citations), Molecular Biology (1.0k citations) and Organic Chemistry (347 citations). Claudio Chuaqui has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Juswinder Singh, Zhan Deng, Nancy Su, Michelle L. Lamb, Qibin Su, Neil P. Grimster, Brian Aquila, Alexander W. Hird, Wen‐Cherng Lee and Philip B. Rawlins. Their work appears in journals such as Cancer Research, Journal of Medicinal Chemistry and Nature Chemical Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact